News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Cellares Automates TScan's TCR-T Manufacturing for Late-Stage AML Trial
TScan and Cellares will evaluate fully automated production of TSC-101, a donor-derived T cell therapy for blood cancers. The pilot targets commercial readiness ahead of a pivotal trial expected to start Q2 2026.
Incyte Expands Genesis AI Drug Deal to $1B+ on Early Wins
Incyte and Genesis Molecular AI doubled down on their partnership after 15 months showed results on hard-to-drug targets. The deal now covers five programs with potential payouts exceeding $1 billion—here's what actually worked.
Hookworm Engineered to Produce Antibodies Inside Human Host
Researchers at WashU Medicine genetically modified hookworms to secrete therapeutic antibodies. The preclinical proof-of-concept shows parasites can act as long-term drug factories inside the body.
90-120 min of strength training cuts death risk by 13%, study finds
A 30-year Harvard-led study published in the British Journal of Sports Medicine shows strength training at 90-120 minutes weekly reduces all-cause mortality by 13%. Combined with aerobic exercise, the benefit climbs to 53-58%.
1.5M deaths yearly from unsafe food, WHO warns after 194-country analysis
WHO studied two decades of data across 194 countries and found contaminated food kills 1.5 million people annually, with under-fives at 3x higher risk. Africa and Southeast Asia account for 75% of cases.
Seven PE Firms Race for 25% of India's Largest Maternity Chain at $1B Valuation
Warburg Pincus, KKR, TPG, and others bid for stake in Cloudnine. The maternity and pediatric hospital operator reported ₹2,000 crore revenue and ₹300 crore EBITDA in FY26.
Three travelers from Ebola regions placed in 21-day home isolation in India
Chhattisgarh officials placed three asymptomatic returnees from Democratic Republic of Congo, Ethiopia, and Uganda under home isolation as precaution after WHO declared Ebola a public health emergency.
Indian hospitals overcharge by design, not complexity
Superhealth CEO argues hospital business models, not medical unpredictability, drive India's high healthcare costs. Pricing for identical procedures varies widely despite low genuine clinical variance.
Healthcare exits favor AI-embedded workflows, not growth stories
Healthcare's exit market is separating well-funded startups from margin-focused companies. Buyers now pay premium prices for AI tools that expand profits, not vanity metrics.
Four factors that determine whether your hospital's AI project will fail
Nordic surveyed healthcare organizations to identify what separates successful AI pilots from failed implementations. The gap usually comes down to data ownership, governance, and workforce readiness.
Healthcare Orgs Need AI Cybersecurity Playbook, Not Just Rules
HSCC released a governance framework for hospitals deploying AI in clinical settings. It covers model drift, data poisoning, and supply chain risks — here's what's inside.
Healthcare AI Needs Operating Models, Not Just Algorithms
HIMSS is hosting AI-focused leadership summits in Boston (June 25-26) and Singapore (August 23-25) to push health systems past pilots into evidence-based deployment. Here's what's actually blocking adoption.